新型冠病毒肺炎合并心肌损伤机制及处理原则浅析  

Mechanism and treatment of coronavirus disease-19 with cardiac injury- a brief discussion

作　　者：赵全明[1] ZHAO Quanming(Department of Cardiology,Beijing Anzhen Hospital,Capital Medical University,Beijing Institute of Heart,Lung and Blood Vessel Diseases,Beijing 100029,China)

机构地区：[1]首都医科大学附属北京安贞医院-北京市心肺血管疾病研究所心内科,100029

出　　处：《心肺血管病杂志》2020年第3期236-240,共5页Journal of Cardiovascular and Pulmonary Diseases

基　　金：国家自然基金(81870368)。

摘　　要：新型冠状病毒肺炎(COVID-19)于2019年12月在中国武汉出现,后经确认为新型冠状病毒感染所致,该新型冠状病毒属于β冠状病毒属,与人类SARS冠状病毒及中东呼吸综合征冠状病毒类似,均可感染人类。该肺炎虽主要引起呼吸道症状,但报道称部分患者合并心肌损伤。本综述简要探讨COVID-19合并心肌损伤可能机制,为抗疫一线医师治疗合并心肌损伤的COVID-19患者提供参考。Coronavirus disease-19(COVID-19) was discovered in Wuhan, Hubei in December 2019. The pathogene was quickly confirmed to be a new coronavirus, which belongs to beta-coronavirus. This new coronavirus was similar to the severe acute respiratory syndrome coronavirus(SARS-CoV), and Middle East respiratory syndrome coronavirus(MERS-CoV), which can also infect human. Although the new coronavirus mainly causes respiratory symptom, studies also observed cardiac injury in some COVID-19 patients. Thus, we briefly reviewed the mechanism of cardiac injury in those COVID-19 patients. We hope this review could contribute to the diagnose and treatment of those COVID-19 patients.

关 键 词：新型冠状病毒肺炎 心肌损伤 

分 类 号：R54[医药卫生—心血管疾病]